Frequent mutations of SARS-CoV-2 have reduced the effectiveness of vaccines, highlighting the need for mutation-resistant ...
News-Medical.Net on MSN2d
Breakthrough peptide inhibitor effective against multiple SARS-CoV-2 variantsSARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.
AZoLifeSciences on MSN3d
Bispecific antibodies for SARS-CoV-2 variant neutralizationBispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...
Emergent BioSolutions (EBS) and Rocketvax announced entry into an agreement for Emergent’s strategic financial investment into Swiss Rockets, ...
Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...
Dropping everything-or being forced to-for COVID-19 had widespread effects. On this fifth anniversary of the pandemic, three ...
The pandemic hit Manchester much like it did elsewhere in the country, and across the world - suddenly and shockingly, ...
Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, and Rocketvax Ltd, one of Switzerland’s next ...
The pandemic hit Manchester much like it did elsewhere in the country, and across the world - suddenly and shockingly, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback